Continuation of low-molecular-weight heparin treatment for cancer-related venous thromboembolism: a prospective cohort study in daily clinical practice-Reference-Cited by-同舟云学术

Continuation of low-molecular-weight heparin treatment for cancer-related venous thromboembolism: a prospective cohort study in daily clinical practice

Published:2016-12-24 Issue:1 Volume:15 Page:74-79
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

van der Wall S. J.¹,Klok F. A.¹,den Exter P. L.¹,Barrios D.²,Morillo R.²,Cannegieter S. C.³,Jimenez D.²,Huisman M. V.¹

Affiliation:

1. Department of Thrombosis and Hemostasis; Leiden University Medical Center; Leiden the Netherlands

2. Respiratory Department; Ramon y Cajal Hospital IRYCIS; Seville Spain

3. Department of Clinical Epidemiology; Leiden University Medical Center; Leiden the Netherlands

Funder

Aspen Pharmaceuticals

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.13563/fullpdf

Reference20 articles.

1. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy;Khorana;J Thromb Haemost,2007

2. Venous thromboembolism and cancer: risks and outcomes;Lee;Circulation,2003

3. Malignancies, prothrombotic mutations, and the risk of venous thrombosis;Blom;JAMA,2005

4. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer;Lee;N Engl J Med,2003

5. Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: a randomized clinical trial;Lee;JAMA,2015

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Avoiding the needle: A quality improvement program introducing apixaban for extended thromboprophylaxis after major gynecologic cancer surgery;Gynecologic Oncology;2024-09

2. Direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer-associated venous thrombosis: a cost-effectiveness analysis;Journal of Pharmaceutical Policy and Practice;2024-07-17

3. Antithrombotic Therapy in Cancer Patients with Cardiovascular Diseases: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society for Thrombosis and Hemostasis Research (GTH e.V.);Hämostaseologie;2024-07-15

4. Effectiveness and safety of continuous low-molecular-weight heparin versus switching to direct oral anticoagulants in cancer-associated venous thrombosis;Nature Communications;2024-07-05

5. The Role of Direct Oral Anticoagulants in the Treatment of Cancer-Associated Venous Thromboembolism: Review by Middle East and North African Experts;Journal of Blood Medicine;2024-04